• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Catalog Number 1125225-15
Health Effect - Clinical Codes Renal Failure (2041); No Code Available (3191)
Date of Event 03/14/2018
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.Concomitant medical products: stent: 2.50 x 28 xience alpine.The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling of the device.
 
Event or Problem Description
It was reported that a 2.25 x 15mm xience alpine and a 2.50 x 28mm xience alpine stents were implanted on (b)(6) 2018.The patient presented with non-st-elevation myocardial infarction (nstemi) before the procedure.On (b)(6) 2018, the patient was readmitted with cardiovascular symptoms and acute kidney failure.Treatment performed was unspecified and the final patient outcome is unknown.No additional information was provided.
 
Additional Manufacturer Narrative
Patient codes: 2041 labeled.Internal file number - (b)(4).Patient coding correction: added code 2041.The reported patient effect of renal failure is listed in the xience alpine, everolimus eluting coronary stent system (eecss), instructions for use (ifu) as a known patient effect of coronary stenting procedures.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Common Device Name
DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
MDR Report Key7542839
Report Number2024168-2018-03914
Device Sequence Number130990
Product Code NIQ
UDI-Device Identifier08717648199073
UDI-Public08717648199073
Combination Product (Y/N)N
Initial Reporter StateIL
Initial Reporter CountryUS
PMA/510(K) Number
P110019
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2018
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Other Health Care Professional
Remedial Action Other
Type of Report Initial,Followup
Report Date (Section B) 04/03/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date08/29/2020
Device Catalogue Number1125225-15
Device Lot Number7081641
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 05/17/2018
Supplement Date Received by Manufacturer03/22/2019
Initial Report FDA Received Date05/24/2018
Supplement Report FDA Received Date04/03/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
SEE H10 FOR CONCOMITANT MEDICAL DEVICES
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient Age60 YR
Patient Weight122
-
-